AVBP logo

AVBP
ArriVent BioPharma Inc.

137
Mkt Cap
$1.1B
Volume
180,269.00
52W High
$27.22
52W Low
$15.55
PE Ratio
-5.60
AVBP Fundamentals
Price
$24.97
Prev Close
$24.89
Open
$24.89
50D MA
$23.10
Beta
1.00
Avg. Volume
597,207.15
EPS (Annual)
-$4.32
P/B
3.45
Rev/Employee
$0.00
$461.06
Loading...
Loading...
News
all
press releases
Wall Street Analysts Think ArriVent BioPharma, Inc. (AVBP) Could Surge 72.44%: Read This Before Placing a Bet
The mean of analysts' price targets for ArriVent BioPharma, Inc. (AVBP) points to a 72.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·19h ago
News Placeholder
More News
News Placeholder
ArriVent BioPharma (NASDAQ:AVBP) Trading Up 8.4% - Here's Why
ArriVent BioPharma (NASDAQ:AVBP) Trading 8.4% Higher - Still a Buy...
MarketBeat·7d ago
News Placeholder
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twelve analysts that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has assigned...
MarketBeat·8d ago
News Placeholder
Are Medical Stocks Lagging ArriVent BioPharma, Inc. (AVBP) This Year?
Here is how ArriVent BioPharma, Inc. (AVBP) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.
Zacks·12d ago
News Placeholder
ArriVent BioPharma (NASDAQ:AVBP) Upgraded to Strong-Buy at Truist Financial
Truist Financial raised shares of ArriVent BioPharma to a "strong-buy" rating in a research note on Wednesday...
MarketBeat·12d ago
News Placeholder
ArriVent BioPharma (NASDAQ:AVBP) Price Target Raised to $45.00 at B. Riley Financial
B. Riley Financial upped their price target on ArriVent BioPharma from $37.00 to $45.00 and gave the company a "buy" rating in a report on Monday...
MarketBeat·15d ago
News Placeholder
ArriVent BioPharma (AVBP) Expected to Announce Quarterly Earnings on Thursday
ArriVent BioPharma (NASDAQ:AVBP) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at...
MarketBeat·19d ago
News Placeholder
ArriVent BioPharma, Inc. $AVBP Shares Sold by Hidden Lake Asset Management LP
Hidden Lake Asset Management LP cut its stake in ArriVent BioPharma, Inc. (NASDAQ:AVBP - Free Report) by 48.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The...
MarketBeat·22d ago
News Placeholder
ArriVent BioPharma's (AVBP) Buy Rating Reaffirmed at BTIG Research
BTIG Research reissued a "buy" rating and set a $42.00 target price on shares of ArriVent BioPharma in a research report on Thursday...
MarketBeat·26d ago
News Placeholder
ArriVent BioPharma (NASDAQ:AVBP) Sees Strong Trading Volume - Here's What Happened
ArriVent BioPharma (NASDAQ:AVBP) Sees Strong Trading Volume - Here's Why...
MarketBeat·28d ago
<
1
2
...
>

Latest AVBP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.